Tumor Mapping in Two Large Multigenerational Families With CYLD Mutations

In 2009, researchers studied 34 individuals from two families with CYLD mutations to understand the clinical features of related skin tumors. They found significant variability in symptoms and tumor locations, with an average onset age of 16. The study revealed that CYLD mutations lead to a range of skin tumors, with 50 different mutations identified, mostly at the gene's carboxyl terminus. This variability complicates genetic counseling and prognostication. The term "CYLD cutaneous syndrome" was proposed to encompass the range of associated clinical diagnoses. The study also noted the limited effectiveness of topical aspirin and the potential for treatments targeting the nuclear factor KB pathway, emphasizing the need for further research in this area.